Company Filing History:
Years Active: 2014-2015
Title: Sun-Yung Jung: Innovator in Neurological Research
Introduction
Sun-Yung Jung is a prominent inventor based in Radnor, PA (US). He has made significant contributions to the field of neurological research, particularly in the treatment of diseases such as Alzheimer's. With a total of 2 patents, his work focuses on innovative methods for evaluating pharmaceutical compositions aimed at addressing cognitive dysfunction.
Latest Patents
One of Sun-Yung Jung's latest patents involves identifying agents to treat Alzheimer's disease-related decreased sorting behavior. This method utilizes a triple transgenic mouse model expressing mutant forms of APP, presenilin, or tau. The invention is particularly useful for evaluating pharmaceutical compositions for neurological diseases associated with cognitive dysfunction, including dementia, schizophrenia, anxiety, depression, and pain. The method employs a rodent behavioral assay to test compositions that may modulate, ameliorate, prevent, or treat dementia.
Another significant patent by Jung is focused on methods for suppressing toll-like receptor activity. This patent discloses agents that interfere with the translocation of Toll-like receptor 3 (TLR3), along with methods for making and using these agents.
Career Highlights
Sun-Yung Jung is currently affiliated with Janssen Biotech, Inc., where he continues to advance his research in neurological disorders. His work has garnered attention for its potential impact on the treatment of debilitating conditions that affect cognitive function.
Collaborations
Throughout his career, Jung has collaborated with notable colleagues, including Mary Birchler and Jarrat Jordan. These collaborations have contributed to the development of innovative solutions in the field of neuroscience.
Conclusion
Sun-Yung Jung's contributions to neurological research through his patents and collaborations highlight his commitment to advancing treatments for cognitive dysfunction. His innovative approaches have the potential to significantly impact the lives of individuals affected by neurological diseases.